Ranbaxy has filed a complaint against the US Food and Drug Administration (FDA) in an American federal court for revoking approvals to market generic versions of patented drugs — Astra Zeneca's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback